Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) to List 40,820 Additional Shares Following Exercise of Stock Options

Posted on September 25, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) to List 40,820 Additional Shares Following Exercise of Stock Options

Source Fact: Financial Supervisory Service DART / 2025-09-25

Disclosure Type: Additional Listing

💡 3-Second Summary

Alteogen will list an additional 40,820 common shares on September 30, following the exercise of stock options.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Type and Number of Additional Shares: 40,820 Common Shares
  • Par Value per Share: KRW 500
  • Reason for Additional Listing: Exercise of stock options
  • Detailed Exercise Breakdown (Issue Date: 2025-09-17):
    • 114th Round: 38,000 shares (Exercise price: KRW 63,889)
    • 115th Round: 2,400 shares (Exercise price: KRW 62,858)
    • 116th Round: 420 shares (Exercise price: KRW 47,417)
  • Listing Date: September 30, 2025
  • Total Number of Listed Shares After Listing: 53,505,788 Common Shares
  • Dividend Accrual Date: January 1, 2025

📈 2. [Expert View: What This Disclosure Means for Investors]

This disclosure is an announcement that new common shares will be issued and additionally listed on the market due to the exercise of previously granted stock options. A total of 40,820 common shares will be added, which increases the total number of listed shares to 53,505,788 shares.

The exercise prices for the newly listed shares range from a minimum of KRW 47,417 to a maximum of KRW 63,889 per share depending on the round. The text of the disclosure does not describe any other financial implications or specific impacts beyond the increase in the number of shares due to the stock option exercise. Investors should focus strictly on the confirmed facts, such as the number of shares to be listed and the scheduled date of September 30, 2025, as provided in the official text.

📝 Editor’s Comment (by K-STOCK Editor)

The additional listing announced by Alteogen involves 40,820 common shares issued through the exercise of stock options. The exercise prices are set at KRW 47,417, KRW 62,858, and KRW 63,889 respectively, with the listing scheduled for September 30, 2025. Investors should focus on the disclosed share count and listing schedule as provided in the official text.

📢 Disclaimer & Source Information

Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Bio & Healthcare, Disclosures

Post navigation

Previous Post: [Disclosure] JUSUNG ENGINEERING (036930) Announces CEO Change; Transitions to Joint CEO Structure Leading by Founder and 2nd-Gen Successor
Next Post: [Disclosure] Alteogen (196170) to List 40,820 Additional Common Shares Following Executive Stock Option Exercises

Related Posts

[Disclosure] Alteogen(196170) Resolves to Submit Agenda for Conditional KOSDAQ Delisting and KOSPI Transfer to Shareholders’ Meeting Disclosures
[Disclosure] Alteogen (196170) to Host Domestic IR in Yeouido, Signaling Major Updates on Bio Platform & Pipelines Disclosures
[Disclosure] Alteogen (196170) Announces AGM Results; Re-election of CEO Park Soon-jae and Approval of All Proposed Agendas Disclosures
[Disclosure] Alteogen(196170) to Receive KRW 21.9B Milestone Payment from MSD for ‘Keytruda SC’ European Approval Disclosures
[Disclosure] Alteogen (196170) to Host Investor Relations (IR) Conference for Major Overseas Institutional Investors Disclosures
[Disclosure] Alteogen(196170) Approves Delisting from KOSDAQ and Relisting on KOSPI at Extraordinary Shareholders’ Meeting Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme